Biopharmaceutical Development Service

Contact Us

CRO Service
Recombinant Protein Production Service
E.coli expression service
Mammalian Transient Protein Expression Service
Yeast expression service
Baculovirus-Insect Cell Protein Expression Service
HEK293/CHO Stable Cell Line Development Service
Antibody Development & Production Service
High-throughput Antibody Production Service+
Mini-scale Antibody Production Service(0.1mg-1mg)
Small-Mid scale Recombinant Antibody Production Service(1mg-100mg)
Large-scale Recombinant Antibody Production Service
Rabbit Monoclonal Antibody Development Service
Mouse Monoclonal Antibody Development Service
Rabbit Polyclonal Antibody Development Service
Hybridoma Cell Culture And Antibody Production Service
Hybridoma Antibody Gene Sequencing Service
Antigen Production Service
ELISA Kit Development Service
Biopharmaceutical Service
Therapeutic Antibody Development Service+
Protein antigen production
Peptide design & synthesis
Mouse monoclonal antibody development
Rabbit monoclonal antibody development
Hybridoma cell culture and antibody production
Monoclonal antibody sequencing
High-throughput antibody production
Antibody Engineering Service+
Chimeric antibody production service
Antibody fragment production service
Bispecific antibody production service
Anti-idiotype antibody development service
Biopharmaceutical Analysis Service
Bioprocess Engineering Service

Biopharmaceutical Development Service Features

Sino Biological has a comprehensive antibody drug research and development platform, with experienced scientists and advanced equipments to provide monoclonal antibody preparation, high-throughput antibody production, antibody engineering, and biopharmaceutical analysis services involving physicochemical analysis and biological activities.

Biopharmaceutical Analysis Service

  • • Physicochemical analysis
  • • Cell-based functional assays
  • • Safety
  • • Binding activity

Bioprocess Engineering Service

  • • Antibody transient expression
  • • Antibody stable cell line development
  • • Stability studies

Biopharmaceutical Development Service Highlights

>6,000 protein expression experience
>20,000 antibody screening experience
Successfully screened dozens of candidate antibodies with good biological activity and druggability against several important drug targets
Established cell activity evaluation models for many antibodies against key drug targets (PD-1, PD-L1, and EGFR, etc)
A full set of preclinical research experience for multiple key drug targets